D69.42 Congenital and hereditary thrombocytopenia purpura

Name of the Condition

• Congenital and hereditary thrombocytopenia purpura (ICD Code: D69.42)

Summary

Congenital and hereditary thrombocytopenia purpura is a condition characterized by a reduced platelet count present from birth or inherited, leading to increased bleeding and bruising. It is classified as a primary thrombocytopenia, meaning the low platelet count is not secondary to another disorder. The condition may involve genetic mutations affecting platelet production or function, resulting in a lifelong risk of bleeding complications.

Causes

The causes of congenital and hereditary thrombocytopenia purpura are typically linked to genetic mutations that affect platelet development or survival. These mutations can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner. Examples include defects in genes responsible for megakaryocyte maturation or platelet membrane proteins. Unlike secondary thrombocytopenia, it is not associated with external factors like infections, medications, or other diseases.

Risk Factors

• Family history of bleeding disorders or thrombocytopenia.
• Inherited genetic mutations affecting platelet production.
• Certain ethnic or familial predispositions (varies by specific subtype).
• Consanguinity (increased risk in populations with shared ancestry).

Symptoms

• Easy bruising or purpura (purple skin discoloration) from minor trauma.
• Petechiae (small red/purple spots) on the skin or mucous membranes.
• Prolonged bleeding from minor cuts or injuries.
• Spontaneous nosebleeds or gum bleeding.
• Blood in urine or stools (in severe cases).
• Fatigue or pallor (if anemia develops from chronic bleeding).

Diagnosis

Diagnosis involves a complete blood count (CBC) to confirm low platelet levels, followed by genetic testing to identify inherited mutations. A review of family medical history is critical to establish hereditary patterns. Additional tests, such as bone marrow biopsy or platelet function assays, may be performed to rule out other causes and characterize the specific subtype.

Treatment Options

Treatment focuses on managing bleeding risk and may include platelet transfusions for acute bleeding or severe thrombocytopenia. Long-term management may involve medications to stimulate platelet production (e.g., thrombopoietin receptor agonists) or immunosuppressants if autoimmune mechanisms are suspected. In severe cases, splenectomy or hematopoietic stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the specific genetic subtype and severity of thrombocytopenia. Most individuals manage symptoms with regular monitoring and treatment, though lifelong care is often required. Follow-up typically includes periodic CBCs to track platelet counts and assess bleeding risk. Genetic counseling is recommended for affected families to discuss inheritance patterns and reproductive options.

Complications

• Severe or life-threatening bleeding (e.g., intracranial hemorrhage).
• Chronic anemia from repeated bleeding.
• Increased risk of bleeding during surgery or trauma.
• Potential for secondary complications like iron deficiency anemia.

Lifestyle & Prevention

• Avoid activities with high injury risk (e.g., contact sports).
• Use soft toothbrushes and electric razors to minimize bleeding.
• Avoid medications that affect platelet function (e.g., aspirin, NSAIDs) unless directed by a provider.
• Maintain regular follow-up with a hematologist for monitoring.

When to Seek Professional Help

Seek immediate medical attention for uncontrolled bleeding, severe bruising, or signs of internal bleeding (e.g., blood in urine/stools, severe headache). Routine care should be coordinated with a hematologist to manage chronic symptoms and adjust treatment as needed.

Tips for Medical Coders

When coding for D69.42, ensure documentation specifies the congenital or hereditary nature of the thrombocytopenia and purpura. Include details on genetic testing, family history, or confirmed inheritance patterns to support the diagnosis. Differentiate from secondary thrombocytopenia by confirming the absence of other underlying causes (e.g., infections, medications, or autoimmune disorders). Accurate coding requires clear documentation of the condition’s onset (congenital) and hereditary link.